Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2776-2781

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Girod, W. G.
Right arrow Articles by Lefer, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Girod, W. G.
Right arrow Articles by Lefer, D. J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Cardiomyopathy
Hazardous Substances DB
*CHOLESTEROL
Related Collections
Right arrow Pathophysiology
Right arrow Genetically altered mice
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2776.)
© 1999 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Effects of Hypercholesterolemia on Myocardial Ischemia-Reperfusion Injury in LDL Receptor–Deficient Mice

Wesley G. Girod; Steven P. Jones; Nola Sieber; Tak Yee Aw; David J. Lefer

From the Department of Molecular and Cellular Physiology (S.P.J., N.S., T.Y.A., D.J.L.) and the Department of Surgery (W.G.G.), LSU Medical Center, Shreveport, La.

Correspondence and reprint requests to David J. Lefer, PhD, Department of Molecular and Cellular Physiology, LSU Medical Center, 1501 Kings Highway, Shreveport, LA 71130. E-mail dlefer{at}lsumc.edu

Abstract—Hypercholesterolemia is a primary risk factor for atherosclerosis, coronary artery disease, and myocardial infarction. We subjected low density lipoprotein receptor–deficient (LDLr –/–) and control (wild-type) mice to 30 minutes of myocardial ischemia and 120 minutes of reperfusion. Myocardial infarction per area at risk (AAR) was noted under baseline conditions to be significantly (P<0.05) smaller in the LDLr –/– mice compared with wild-type mice (24.7±3.2% and 38.8±4.3% of AAR, respectively). Subsequently, mice were fed a high-cholesterol diet (HCD) for 2 or 12 weeks, which resulted in significant increases in serum cholesterol levels in both LDLr –/– and wild-type groups. After 2 weeks of the HCD, the LDLr –/– mice demonstrated a significant elevation (P<0.01) in myocardial necrosis per AAR (50.2±5.36% of AAR) compared with the normal-diet LDLr –/– group, whereas the short-term HCD-fed wild-type mice demonstrated no significant difference from baseline. In contrast, wild-type mice fed the HCD for 12 weeks revealed a significant (P<0.05) decrease in necrosis per AAR, which was 22.5±3.2% of the AAR in comparison with that in the normal-diet wild-type mice (38.8±4.3% of AAR). LDLr –/– mice on the same long-term HCD showed a similar significantly (P<0.05) decreased infarct size, which was 13.2±4.0% of the AAR. In additional experiments, we determined that myocardial tissue total glutathione (GSH) levels were reduced after 2 weeks of the HCD and were significantly increased after 12 weeks of the HCD in the LDLr –/– mouse heart. These data suggest that short-term cholesterol feeding renders the myocardium of LDLr –/– mice more susceptible to ischemia-reperfusion injury, whereas more long-term hypercholesterolemia confers cardioprotection in the LDLr –/– mouse heart.


Key Words: infarct • cholesterol • neutrophils • mutant mice




This article has been cited by other articles:


Home page
Toxicol PatholHome page
E. Golomb, A. Nyska, and H. Schwalb
Occult Cardiotoxicity--Toxic Effects on Cardiac Ischemic Tolerance
Toxicol Pathol, August 1, 2009; 37(5): 572 - 593.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
X.-Y. Zhu, E. Daghini, A. R. Chade, D. Versari, J. D. Krier, K. B. Textor, A. Lerman, and L. O. Lerman
Myocardial microvascular function during acute coronary artery stenosis: effect of hypertension and hypercholesterolaemia
Cardiovasc Res, July 15, 2009; 83(2): 371 - 380.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. Ferdinandy, R. Schulz, and G. F. Baxter
Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning
Pharmacol. Rev., December 1, 2007; 59(4): 418 - 458.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Dworschak, L. V. d'Uscio, D. Breukelmann, and J. D. Hannon
Increased tolerance to hypoxic metabolic inhibition and reoxygenation of cardiomyocytes from apolipoprotein E-deficient mice
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H160 - H167.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
T. De Celle, J. P. Cleutjens, W. M. Blankesteijn, J. J. Debets, J. F. Smits, and B. J. Janssen
Long-term structural and functional consequences of cardiac ischaemia-reperfusion injury in vivo in mice
Exp Physiol, September 1, 2004; 89(5): 605 - 615.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Dziedzic, A. Slowik, E. A. Gryz, and A. Szczudlik
Lower Serum Triglyceride Level Is Associated With Increased Stroke Severity
Stroke, June 1, 2004; 35(6): e151 - e152.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Galinanes and A. G Fowler
Role of clinical pathologies in myocardial injury following ischaemia and reperfusion
Cardiovasc Res, February 15, 2004; 61(3): 512 - 521.
[Abstract] [Full Text] [PDF]